meropenem and evernimicin

meropenem has been researched along with evernimicin* in 1 studies

Other Studies

1 other study(ies) available for meropenem and evernimicin

Article	Year
In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:7 The in vitro activity of the everninomicin antibiotic SCH 27899 against 17 isolates of Borrelia spp. was investigated. MICs ranged from 0.06 to 0.5 microg/ml. Time-kill studies with the B31 strain of B. burgdorferi demonstrated >/=3-log10-unit killing after 72 h with concentrations representing four times the MIC. The in vitro activity of four other newer antimicrobial agents, meropenem, cefepime, quinupristin-dalfopristin, and linezolid, was also tested against the B31 strain. Meropenem was the most potent of the latter agents, with an MIC of 0.125 microg/ml. Topics: Aminoglycosides; Anti-Bacterial Agents; Borrelia burgdorferi Group; Ceftriaxone; Doxycycline; Meropenem; Microbial Sensitivity Tests; Thienamycins	1999

Article

Year

In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.

Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:7

The in vitro activity of the everninomicin antibiotic SCH 27899 against 17 isolates of Borrelia spp. was investigated. MICs ranged from 0.06 to 0.5 microg/ml. Time-kill studies with the B31 strain of B. burgdorferi demonstrated >/=3-log10-unit killing after 72 h with concentrations representing four times the MIC. The in vitro activity of four other newer antimicrobial agents, meropenem, cefepime, quinupristin-dalfopristin, and linezolid, was also tested against the B31 strain. Meropenem was the most potent of the latter agents, with an MIC of 0.125 microg/ml.

Topics: Aminoglycosides; Anti-Bacterial Agents; Borrelia burgdorferi Group; Ceftriaxone; Doxycycline; Meropenem; Microbial Sensitivity Tests; Thienamycins

1999